The modified International Prognostic Index can predict the outcome of localized primary intestinal lymphoma of both extranodal marginal zone B‐cell and diffuse large B‐cell histologies
Sergio Cortelazzo(Azienda Ospedaliero-Universitaria delle Marche), Elena Oldani(Ospedale Papa Giovanni XXIII), Andrea Rossi(Fondazione Toscana Gabriele Monasterio), Franco Cavalli(Institute of Social and Preventive Medicine), Henry Gómez(National Cancer Center), Tiziano Barbui(University of Bergamo), Roberto Giardini(Fondazione IRCCS Istituto Nazionale dei Tumori), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Liliana Devizzi(Fondazione IRCCS Istituto Nazionale dei Tumori), Pier Luigi Zinzani(Istituto di Ematologia di Bologna), Emanuele Zucca(Università della Svizzera italiana), Alessandro M. Gianni(University of Milan), Graziella Pinotti(Medica (Italy)), Claudio Chini(Aziende Socio Sanitarie Territoriale dei Sette Laghi), Teresio Motta(International Extranodal Lymphoma Study Group)
Cited by 18
Related Papers
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
|European Respiratory Journal|2004|4.4k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751